Cramer's Take on Top-Searched Stocks

Here's what Jim Cramer's had to say lately about Goldman Sachs.
Author:
Publish date:

Updated from 7:03 a.m. EDT

What a difference a week can make! The

S&P 500

gained 10% in what was the strongest week on Wall Street since November.

Friday was a good day for health care stocks, with

Merck

(MRK) - Get Report

gaining 14% after being upgraded by an analyst. The blue-chip drug manufacturer got a boost on new drug trial data out from

Schering-Plough

(SGP)

, a company it is trying to acquire. Other big health care movers included

Johnson & Johnson

(JNJ) - Get Report

and

Pfizer

(PFE) - Get Report

.

Despite the big move in the markets this week, investors still want to know if we've seen the bottom. Will the market continue to recover?

With this in mind, we thought we'd take a look at some of the stocks people have been searching for on

TheStreet.com

(including

Goldman Sachs

(GS) - Get Report

) and see what

Jim Cramer's had to say from them lately

.

To read more,

visit Stockpickr.com

.

In Monday trading, shares of Goldman Sachs closed at $93.90 (down 4.96% for the day; up 3.1% for the month).

Stockpickr is a wholly owned subsidiary of TheStreet.com.